1. Home
  2. Research
  3. Research Groups
  4. Molecular Pathology of Cancer Group

Molecular Pathology of Cancer Group

Search for publications

Only original articles, editorials, guidelines.

  • Jiménez Zapata HD, Rojas Medina LM, Carrasco Moro R, Martínez Rodrigo A, García-Cosio Piqueras M.

    Cauda equina syndrome secondary to neurolymphomatosis: Case report and literature review.

    NEUROCIRUGIA . 29(3): 138-142. Number of citations: 1

    [doi:10.1016/j.neucir.2017.07.001]

  • Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

    Recomendaciones para la determinación de biomarcadores en cáncer de ovario epitelial. Consenso nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica.

    REVISTA ESPANOLA DE PATOLOGIA . 51(2): 84-96.

    [doi:10.1016/j.patol.2017.11.002]

  • Palacios Calvo J, Albanell J, Rojo F, Ciruelos E, Aranda-López I, Cortés J, García-Caballero T, Martín M, López-García MÁ, Colomer R.

    Consenso de la Sociedad Española de Anatomía Patológica y la Sociedad Española de Oncología Médica sobre biomarcadores en cáncer de mama.

    REVISTA ESPANOLA DE PATOLOGIA . 51(2): 97-109.

    [doi:10.1016/j.patol.2017.12.002]

  • Pacios Blanco RE, Gorospe Sarasua L, Reguero ME.

    Spontaneous Bilateral Pneumothoraces in Erdheim-Chester Disease.

    ARCHIVOS DE BRONCONEUMOLOGIA . 54(4): 219-219.

    [doi:10.1016/j.arbres.2017.08.004]

  • Garrido P, Aldaz A, Vera R, Calleja MA, de Álava E, Martín M, Matías-Guiu X, Palacios J.

    Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(4): 443-447. Number of citations: 14

    [doi:10.1007/s12094-017-1740-0]

  • Pinto-Díez C, García-Recio EM, Pérez-Morgado MI, García-Hernández M, Sanz-Criado L, Sacristán S, Toledo-Lobo MV, Pérez-Mies B, Esteban-Rodríguez I, Pascual A, Garcia-Villanueva M, Martínez-Jañez N, González VM, Martín ME.

    Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.

    Oncotarget . 9(17): 13501-13516.

    [doi:10.18632/oncotarget.24417]

  • Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

    Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 424-424. Number of citations: 1

    [doi:10.1007/s12094-017-1746-7]

  • Burgués O, López-García MÁ, Pérez-Míes B, Santiago P, Vieites B, García JF, Peg V.

    The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 382-391. Number of citations: 2

    [doi:10.1007/s12094-017-1725-z]

  • Oaknin A, Guarch R, Barretina P, Hardisson D, González A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

    Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 274-285. Number of citations: 5

    [doi:10.1007/s12094-017-1719-x]

  • Espinosa I, De Leo A, D'Angelo E, Rosa-Rosa JM, Corominas M, Gonzalez A, Palacios J, Prat J.

    Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.

    HUMAN PATHOLOGY . 72: 100-106. Number of citations: 20

    [doi:10.1016/j.humpath.2017.11.006]

  • Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, Chudecka-Glaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubinski J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Eilber U, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, deFazio A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido Dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ.

    Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

    JAMA Oncology . 3(12): .

    [doi:10.1001/jamaoncol.2017.3290]

  • Gómez-Mariscal M, Oleñik A, Arriba-Palomero P, García-Cosio M, Muñoz-Negrete FJ.

    Recurrent Bilateral Anterior Uveitis with Kikuchi-Fujimoto Disease.

    OCULAR IMMUNOLOGY AND INFLAMMATION . 25(6): 866-869. Number of citations: 3

    [doi:10.1080/09273948.2016.1188966]

  • Garrido P, Aldaz A, Calleja MÁ, De Álava E, Lamas MJ, Martín M, Matías-Guiu X, Palacios J, Vera R.

    Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.

    FARMACIA HOSPITALARIA . 41(6): 688-691.

    [doi:10.7399/fh.10877]

  • Martín M, Chacón JI, Antón A, Plazaola A, García-Martínez E, Seguí MA, Sánchez-Rovira P, Palacios J, Calvo L, Esteban C, Espinosa E, Barnadas A, Batista N, Guerrero A, Muñoz M, Romio E, Rodríguez-Martín C, Caballero R, Casas MI, Rojo F, Carrasco E, Antolín S.

    Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.

    ONCOLOGIST . 22(11): 1301-1308. Number of citations: 9

    [doi:10.1634/theoncologist.2017-0052]

  • Gayarre J, Martín-Gimeno P, Osorio A, Paumard B, Barroso A, Fernández V, de la Hoya M, Rojo A, Caldés T, Palacios J, Urioste M, Benítez J, García MJ.

    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.

    BRITISH JOURNAL OF CANCER . 117(7): 1048-1062. Number of citations: 6

    [doi:10.1038/bjc.2017.286]

  • Garrido P, Olmedo ME, Gómez A, Paz Ares L, López-Ríos F, Rosa-Rosa JM, Palacios J.

    Treating KRAS -mutant NSCLC: latest evidence and clinical consequences.

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 9(9): 589-597. Number of citations: 26

    [doi:10.1177/1758834017719829]

  • Espinosa I, Lee CH, D'Angelo E, Palacios J, Prat J.

    Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis.

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY . 41(8): 1121-1128. Number of citations: 49

    [doi:10.1097/PAS.0000000000000873]

  • Vaca M, Polo R, Martínez-San-Millán J, Reguero ME, Pérez C, Cordero A, Medina MD, Cobeta I.

    Pigmented Villonodular Synovitis of the Temporomandibular Joint With Petrous Bone Invasion.

    OTOLOGY & NEUROTOLOGY . 38(5): . Number of citations: 3

    [doi:10.1097/MAO.0000000000001390]